1. KD. Tripathi. Antidiuretics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 596-597.
2. Robert F. Reilly and Edwin K. Jackson. Regulation of renal function and vascular volume. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 708-714.
3. Roger K. Long & Hakan Cakmak. Hypothalamic & Pituitary Hormones. Basic and Clinical Pharmacology. 14th Edition. New York McGarw Hill Education 2018. Page – 681-682.
4. Gerald G. Briggs and Roger K. Freeman. D. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 1085-1086.
5. Teva Pharmaceuticals USA. Desmopressin Acetate 0.2 mg Tablets, Fasting. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on September 2009] [Accessed 26th November 2020] https://clinicaltrials.gov/ct2/show/NCT00835211
6. Ferring Pharmaceuticals. Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on November 2015] [Accessed 26th November 2020] https://clinicaltrials.gov/ct2/show/NCT00477490
7. Fara M. Friedman and Jeffrey P. Weiss. Desmopressin in the treatment of nocturia: clinical evidence and experience. NCBI; PMC US National Library of Medicine, National Institute of Health. December 2013. [Accessed 26th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825109/
8. Ferring GmbH. Electronic Medicines Compendium (EMC); [Revised on October 2011] [Accessed 26th November 2020] https://www.medicines.org.uk/emc/files/pil.1285.pdf
9. Ferring GmbH. Health Products Regulatory Authorities (HPRA); [Revised on April 2015] [Accessed 26th November 2020] https://www.hpra.ie/img/uploaded/swedocuments/PA1009-1-3%20PIL-2162024-08052015145558-635666937589703750.pdf